Interoceptive Exposure for Adolescents With Low Weight Eating Disorders
A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents With Low Weight Eating Disorders
2 other identifiers
interventional
120
1 country
1
Brief Summary
This project includes a parallel group randomized controlled trial comparing two psychological treatments: 1) Exposure-based Family Therapy (IE) vs. 2) Family Based Therapy (FBT) for low weight eating disorders with 12 month follow-up. Primary outcomes are expected body weight and clinical impairment. Three mechanisms of change (Autonomous Eating, Non-Judgmental Body Awareness, and Extinction Learning) will be examined in a process mediation models of change.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2023
CompletedFirst Posted
Study publicly available on registry
March 10, 2023
CompletedStudy Start
First participant enrolled
March 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
June 4, 2025
May 1, 2025
4.8 years
February 28, 2023
May 30, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Change in Expected Body Weight Percentage
Expected body weight percentage will be calculated at baseline and end of treatment (6-months) to calculate difference.
Baseline and 6-months
Change in Expected Body Weight Percentage
Expected body weight percentage will be calculated at baseline and 1 year after treatment (18-months) to calculate difference.
Baseline and 18-months
Change in Impairment
Impairment is measured using the Clinical Impairment Assessment, which is a 16-item self-report measure of impairment from eating disorders. Responses are scored using 0, 1, 2, or 3 and the score is calculated using the sum of all items. Possible scores range between 0 - 48, with higher scores indicating more impairment and lower scores indicating less impairment. Change in impairment will be calculated using the baseline and end of treatment (6-months) scores from CIA.
Baseline and 6-months
Change in Impairment
Impairment is measured using the Clinical Impairment Assessment, which is a 16-item self-report measure of impairment from eating disorders. Responses are scored using 0, 1, 2, or 3 and the score is calculated using the sum of all items. Possible scores range between 0 - 48, with higher scores indicating more impairment and lower scores indicating less impairment. Change in impairment will be calculated using the baseline and 1 year after treatment (18-months) scores from CIA.
Baseline and 18-months
Secondary Outcomes (8)
Change in Autonomous Eating
Baseline and 6-months
Change in Autonomous Eating
Baseline and 18-months
Change in Food Cue Learning
Baseline and 6-months
Change in Food Cue Learning
Baseline and 18-months
Change in Eating Disorder Symptoms
Baseline and 6-months
- +3 more secondary outcomes
Study Arms (2)
Interoceptive Exposure Treatment (IE)
EXPERIMENTALInteroceptive Exposure Therapy (IE) targets food avoidance, food exposure, and body image exposure.
Family-Based Treatment (FBT)
ACTIVE COMPARATORFamily-Based Therapy (FBT) focuses on parent-enforced contingencies, increasing value of eating, and decreasing the value of food avoidance.
Interventions
Interoceptive Exposure Therapy (IE) targets food avoidance in Anorexia Nervosa. Each session the therapist weighs the patient, checks-in, and reviews weekly homework. Sessions occur weekly for 20 weeks, with the first session lasting 1.5 hours and the remaining sessions one hour. Early sessions include using exposure to foods and counterconditioning to pair a positive stimulus with a food that would typically produce food avoidance. Parents are trained to model this at home. Sessions mid-way through address the use of non-judgmental description of appearance during mirror exposure. Sessions at the end of the 20 weeks are focused on recognizing change, planning for future obstacles, and developing a relapse prevention plan to continue practicing distress tolerance, counter-conditioning, and food/body exposure.
Family-Based Therapy (FBT) includes parent-enforced contingencies to increase value of eating and decrease the value of food avoidance. Each session the therapist weighs the patient, checks-in, and reviews weekly homework. Sessions occur weekly for 20 weeks, with the first session lasting 1.5 hours and the remaining sessions one hour. Sessions consist of checking in with the patient, discussion of the week's implementation of refeeding, and helping parents separate the illness from their child. In session 2, a family meal provides the therapist with an opportunity for direct observation of the familial interaction patterns around eating. The therapist makes careful and persistent requests for united parental action toward re-feeding and/or regulating eating habits, the primary concern at this point of the treatment, and the therapist tries to create and reinforce a strong parental alliance around efforts at feeding the child.
Eligibility Criteria
You may qualify if:
- Aged 12-18
- Speak English
- Permission from pediatrician or equivalent to receive outpatient care
- Clinically significant restriction of food intake by EDA-5 or evidence of persistent food avoidance from patient or guardians
- Evidence of the inability to maintain greater than minimally low body weight based on BMI for age percentiles and growth trajectories
You may not qualify if:
- Comorbid psychotic or bipolar disorder
- Active suicidal ideation
- Current substance dependence
- Psychiatric medication initiated or dosage changes \<2 weeks from baseline
- Major medical illness (e.g., diabetes mellitus, Crohn's disease, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychiatry, Eating and Weight Disorders Program
New York, New York, 10028, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Hildebrandt, Psy.D.
Icahn School of Medicine at Mount Sinai
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 28, 2023
First Posted
March 10, 2023
Study Start
March 14, 2023
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2028
Last Updated
June 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, ANALYTIC CODE
- Time Frame
- Specify Other Time FrameTwice yearly and for each publication
- Access Criteria
- Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose. Any purpose. Specify Other Mechanism Data will be made available through the National Institute of Mental Health Data Archive (NDA)
All of the individual participant data collected during the trial, after deidentification.